Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist YM178 in Patients With Symptoms of Overactive Bladder - No Study Results Posted

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist YM178 in Patients With Symptoms of Overactive Bladder (TAURUS)

This study has been completed.

Study NCT00688688 Information provided by Astellas Pharma Inc

First Received: May 29, 2008 Last Updated: May 10, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2010
Primary Completion Date:	May 2010 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: May 10, 2011